U.S. Tech Hardware Stock News

Palomar Holdings (PLMR) drew investor attention after reporting Q1 revenue growth of 59.7% year on year and a 5.8% beat versus analyst expectations, with shares rising about 5% to around $116.30. See our latest analysis for Palomar Holdings. The recent Q1 beat comes on top of a 7.2% 1 day share price return and a 13.1% 7 day share price return, although Palomar Holdings’ 1 year total shareholder return is down 17.6% after a very large 3 year total shareholder return of about 7x. If strong...

Quanta Services (PWR) is in focus after Hyosung HICO agreed to form HYOSUNG HICO BREAKER, LLC, a joint venture that will manufacture high-voltage gas circuit breakers at Quanta's Canonsburg, Pennsylvania, facility. See our latest analysis for Quanta Services. Quanta Services’ recent joint venture news comes after a strong run, with the share price down 4.3% on the day to $687.87 but still showing a 90 day share price return of 28.9% and a 1 year total shareholder return of 80.6%. This...

Recycling earnings and dividend track record move into focus Eastman Chemical (EMN) is drawing fresh attention after its Kingsport methanolysis facility contributed an additional $60 million in earnings in 2025, with another $30 million targeted for 2026, while the company extends a 16-year streak of dividend increases. See our latest analysis for Eastman Chemical. At a share price of $70.71, Eastman Chemical has a year to date share price return of 9.9%, while its 1 month share price return...

In late June 2026, GE Vernova Inc. (NYSE:GEV) was added to the Russell Top 50 Index, following earlier disclosure that it secured about US$2.40 billion in data center equipment orders in the first quarter of 2026 amid rising electrification and grid-modernization demand. This combination of index inclusion and large AI-related power infrastructure orders highlights how GE Vernova is becoming a central supplier to the electricity demands behind data center growth. We will now examine how GE...

Earlier this month, Wix.com Ltd. announced a collaboration with Microsoft Corporation to integrate its Wix Harmony website creation tools directly into Microsoft 365 Copilot, allowing users to generate and manage feature-rich Wix sites via natural-language prompts inside the Microsoft 365 interface. This move effectively embeds Wix's broader ecosystem, covering commerce, scheduling, payments, analytics, and more, into everyday productivity workflows, potentially deepening its reach among...

In recent months, Altria Group has responded to pressure on its traditional cigarette business and tighter regulation by accelerating investment in smoke-free alternatives, particularly oral nicotine pouches, while still maintaining its dividend and share repurchase program. This combination of funding reduced-risk products with cash flows from legacy brands, alongside continued capital returns, highlights how Altria is trying to realign its business model without disrupting shareholder...

With the U.K. economy slipping 0.1% in April 2026 and war driven energy costs squeezing both households and businesses, many investors are rethinking how much risk sits in their portfolios. Defensive Consumer Staples Stocks can sometimes offer a steadier ride when growth cools and rate cuts look distant, but not all stocks respond to the same news in the same way. This article looks at three stocks from a Defensive Consumer Staples Stocks screener that appear positively exposed to the latest...

Fluor stock: new healthcare infrastructure mandate from Voyageur Fluor (FLR) stock is in focus after Voyageur Pharmaceuticals engaged the company to run feasibility studies for two radiology contrast drug projects tied to Bayer backed iodine and barium manufacturing plans. See our latest analysis for Fluor. Fluor's latest healthcare infrastructure mandate comes after a strong run, with a 30 day share price return of 17.22% and a 5 year total shareholder return of 208.63%, suggesting momentum...

IBM (NYSE:IBM) has introduced a sub-1 nanometer "nanostack" chip architecture, described as offering up to 50% more performance or 70% greater energy efficiency compared with current 2 nm chips. The company also launched Anderon, a standalone quantum wafer foundry in the U.S. focused on manufacturing quantum chips at commercial scale. Together, these moves target future AI, data center hardware, and quantum computing demand, and expand IBM's role in semiconductor and quantum...

Comfort Systems USA (FIX) is back in focus after investors digested fresh analyst commentary on its growing project backlog, stronger free cash flow margins, and supportive earnings estimate revisions, alongside recent leadership changes. See our latest analysis for Comfort Systems USA. Despite a sharp 8.1% decline in the 1 day share price return and a softer 7 day share price return, Comfort Systems USA still shows strong momentum, with a 90 day share price return of 45.6% and a very large 5...

UiPath (PATH) is back in focus after mixed Q1 results, where revenue outperformance contrasted with weaker full year billings guidance compared with other automation software stocks, even as new products like Maestro Case gather customer interest. See our latest analysis for UiPath. The share price reaction around UiPath's Q1 release and Maestro Case updates has been choppy. A 6.04% 1 day share price return and 2.53% 7 day share price return sit against a 30 day share price return that is...

Eli Lilly and Company recently received a positive opinion from the European Medicines Agency’s human medicines committee for Jaypirca (pirtobrutinib) to treat adults with chronic lymphocytic leukemia across all lines of therapy, while U.S. Medicare approved a new GLP-1 Bridge program that will give eligible patients access to Zepbound and Foundayo weight-management drugs for a US$50 monthly copay. Together, these developments highlight how Lilly is extending its reach in both oncology and...

Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA approval for Tryngolza (olezarsen) as the first treatment to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia. The company plans a U.S. commercial launch of Tryngolza next month, targeting high risk patients with limited existing options. Ionis also signed a licensing agreement granting Recordati exclusive rights to develop and commercialize zilganersen for Alexander disease outside the U.S.,...

Recently, analyst commentary from Truist pointed to a credible path for Covista’s Chamberlain University to return to mid-to-high single-digit enrollment growth, reinforcing management’s focus on expanding this healthcare education segment. The emphasis on Chamberlain’s potential enrollment recovery highlights how improving student intake at a single, core institution could meaningfully influence Covista’s overall education portfolio and earnings mix. We’ll now examine how this renewed...

Ross Stores (NasdaqGS:ROST) is drawing inflation weary shoppers across income brackets with its value focused, off price model. The company is seeing sustained interest in its brick and mortar stores even as many retailers emphasize digital channels. This contrast highlights Ross Stores' differentiated approach at a time when in person discount shopping continues to appeal to budget conscious consumers. Ross Stores runs an off price retail model built around in store treasure hunt style...

In recent days, analysts raised their consensus revenue forecasts for CRISPR Therapeutics and projected year-over-year EPS growth ahead of the company’s upcoming earnings report. This shift in expectations has drawn attention to how confidence around near-term gene-editing revenue potential may be reshaping perceptions of CRISPR Therapeutics’ business outlook. We’ll now examine how heightened analyst optimism about CRISPR Therapeutics’ near-term revenues could influence the company’s...

With markets watching a softer May jobs report, muted hiring, elevated layoffs, and a Federal Reserve that may be reluctant to shift rates quickly, many investors are taking a fresh look at stocks that could hold up when growth feels less certain. This article focuses on three stocks from a Defensive Sectors screener, all from Utilities, Consumer Staples, and Healthcare, that are directly exposed to the latest labor market news. Each has been selected for financial strength within its sector,...

Recent Share Performance and Business Mix Galaxy Digital (GLXY) has seen mixed share performance recently, with the stock up 3.5% over the past day but down 14.4% over the past week and about 1.1% over the past month. Over the past 3 months, Galaxy Digital is up about 70.6%, with a total return of 46.5% over the past year and a very large gain across the past 3 years. Year to date, the stock is up 18.2%. The company reports annual revenue of US$58,713.02, primarily from its Digital Assets...

Core Natural Resources recently restarted longwall mining at its Leer South mine and secured major contracts across its segments at favorable prices, reinforcing operational momentum despite broader coal industry headwinds. This combination of restored production capacity and contracted volume visibility could meaningfully influence how investors assess the resilience and cash generation profile of the business. We’ll now examine how the Leer South longwall restart and newly secured...

USA Rare Earth (NasdaqGM:USAR) plans to acquire a producing mine in Brazil, with completion targeted for 2026. The company intends to integrate the mine's output into its global value chain to secure non Asian rare earth feedstock. This development is separate from the recent Wheat Ridge facility commissioning and focuses on expanding upstream supply. USA Rare Earth is drawing fresh attention as it moves to add a producing Brazilian mine to its portfolio, reinforcing its role in rare earth...

In June 2026, Campbell’s and Banza launched a new gluten free condensed Chicken Noodle Soup made with chickpea penne pasta, while Campbell’s also announced upcoming retirements and internal promotions in its transformation and communications leadership, and the stock was added to the Russell Small Cap Comp Value Index. This combination of a milestone gluten free product aimed at health-conscious consumers, leadership transitions, and fresh index inclusion highlights how Campbell’s is...

Recent commentary on Laureate Education (LAUR) centers on weak student enrollment growth, flat earnings per share and disappointing free cash flow projections, which raise questions about demand, operational efficiency and the downside risks already reflected in the stock price. See our latest analysis for Laureate Education. At a share price of $37.12, Laureate Education has a 1 month share price return of 16.04% and a 1 year total shareholder return of 60.69%. This puts recent momentum...

Fresh headlines around potential changes to US sanctions on Venezuela have put US oil refiners back in focus, as traders weigh what cheaper heavy crude access could mean for costs, margins, and long term capital plans. This article looks at how that news ties into a curated screener of larger, financially healthier US refining companies, and why the shift in Venezuelan exports away from China toward the US matters for anyone watching energy stocks. Below, you will see 3 stocks from this...

In June 2026, Cleveland Clinic announced a multi-year research collaboration with 10x Genomics to use its Flex Apex, Xenium and future Atera platforms to analyze advanced bladder cancer tumor samples and uncover treatment-response biomarkers for potential diagnostic development. This partnership aims to generate a rich, multimodal dataset that links single-cell and spatial profiles with clinical outcomes, potentially reinforcing 10x Genomics’ role in precision oncology research and future...